April 23, 2020
HHSC has been informed of a drug shortage for Methylphenidate ER in the Stimulants drug class. VDP temporarily removed the non-preferred status from the brand formulations of the NDCs below on April 23. These changes will allow providers to prescribe for these drugs without requiring a PDL prior authorization and allow continued access to necessary medication for clients. This is a temporary change until the preferred products are sufficiently available in the market. VDP will announce any further PDL status changes of these NDCs. Contact firstname.lastname@example.org for more information.
|50458058501||CONCERTA ER 18 MG TABLET|
|50458058601||CONCERTA ER 36 MG TABLET|
|50458058701||CONCERTA ER 54 MG TABLET|
|50458058801||CONCERTA ER 27 MG TABLET|